Effects of fenamate on inhibitory postsynaptic currents in Purkinje's cells

Bulletin of Experimental Biology and Medicine

Volumn 145, Issue 5, 2008, Pages 564-568

  Dvorzhak, A Yu ^a  

^a RESEARCH CENTER OF NEUROLOGY   (Russian Federation)

Author keywords

Cerebellum; Mefenamic acid; Nonsteroid antiinflammatory drugs; Potential fixation method; Tolfenamic acid

Indexed keywords

LYSALGO; MEFENAMIC ACID; TOLFENAMIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; INHIBITORY POSTSYNAPTIC POTENTIAL; MOUSE; NEUROTRANSMISSION; NONHUMAN; PATCH CLAMP; PURKINJE CELL;

ANIMALS; ANTHRANILIC ACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; GAMMA-AMINOBUTYRIC ACID; INHIBITORY POSTSYNAPTIC POTENTIALS; MEFENAMIC ACID; MICE; MICE, INBRED C57BL; MINIATURE POSTSYNAPTIC POTENTIALS; PATCH-CLAMP TECHNIQUES; PURKINJE CELLS;

EID: 55649095936     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-008-0144-0     Document Type: Article

References (13)

1. B. Bannwarth, P. Netter, J. Pourel, et al., Biomed. Pharmacother., 43, No. 2, 121-126 (1989).
2. Q. Chen, J. W. Olney, P. D. Lukasiewicz, et al., Mol. Pharmacol., 53, No. 3, 564-572 (1998).
3. Q. Chen, J. W. Olney, P. D. Lukasiewicz, et al., Neurosci. Lett., 242, No. 2, 163-166 (1998).
4. L. Coyne, J. Su, D. Patten, and R. F. Halliwell, Neurochem. Int., 51, Nos. 6-7, 440-446 (2007).
5. B. Cryer and M. Feldman, Am. J. Med., 104, No. 5, 413-421 (1998).
6. R. F. Halliwell, P. Thomas, D. Patten, et al., Eur. J. Neurosci., 11, No. 8, 2897-2905 (1999).
7. Y. Joo, H. S. Kim, R. S. Woo, et al., Mol. Pharmacol., 69, No. 1, 76-84 (2006).
8. A. V. Krymchantowski and M. E. Bigal, BMC. Neurol., 4, 10 (2004).
9. P. L. McGeer and E. G. McGeer, Neurobiol. Aging, 28, No. 5, 639-647 (2007).
10. E. G. McGeer and P. L. McGeer, CNS Drugs, 21, No. 10, 789-797 (2007).
11. S. C. Smolinske, A. H. Hall, S. A. Vandenberg, et al., Drug Saf., 5, No. 4, 252-274 (1990).
12. J. R. Vane and R. M. Botting, Inflamm. Res., 47, Suppl. 2, S78-S87 (1998).
13. R. M. Woodward, L. Polenzani, and R. Miledi, J. Pharmacol. Exp. Ther., 268, No. 2, 806-817 (1994).